Hypertension Trial, Recruiting NCT05626426 Sponsor: Stanford University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05626426
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who are able and willing to follow the study schedule and attend all required visits
  • People who have been clinically diagnosed with glaucoma, with visual field test results (Humphrey Visual Field 24-2) showing a mean deviation worse than -3, and with reliable test results meeting specific accuracy thresholds
  • People whose eye pressure has been assessed by the study doctor as clinically stable
  • If only one eye qualifies, that eye will be used; if both eyes qualify, the eye with the worse visual field result will be used — and if both eyes are equal, the participant may choose which eye to enter, or one will be assigned randomly
  • People who are able to provide signed informed consent (if vision makes reading difficult, the consent document will be read aloud in full)

Who may not be able to join:

  • People who are unable or unwilling to follow study procedures or attend follow-up visits
  • People with a history of herpes zoster affecting the eye
  • People with a condition causing uncontrolled, involuntary eye movements (pathological nystagmus)
  • People with significant retinal disease, such as diabetic retinopathy or retinitis pigmentosa
  • People with cloudiness or reduced clarity of the cornea (the clear front surface of the eye)
  • People with uveitis or other inflammatory eye conditions
  • People who have any electrical or electronic implants in their body, such as a pacemaker
  • People with an active eye infection such as conjunctivitis
  • People with an active autoimmune disease
  • People who are pregnant or breastfeeding
  • People with a physical or mental condition that the study doctor believes could increase risk or interfere with the study, including any form of dementia
  • People with a brain tumour that has not been surgically removed
  • People who have metallic implants in the head or skull (such as clamps, coils, or certain shunts) that are not safe for use with MRI — note that dental implants and titanium screws or plates are generally acceptable (confirm with trial site)
  • People with any skin damage (confirm with trial site regarding the affected area and relevance)
  • People who are in a coma
  • People with a history of epileptic seizures within the last 10 years
  • People with high blood pressure or diabetes that is not well controlled
  • People who have taken part in a vision training or vision stimulation study within the last 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 February 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline in visual field assessed by Humphrey Visual Field Index (VFI).; Change from baseline in visual field assessed by Humphrey Mean Deviation (MD).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov